| Schedule of Components of Basic and Diluted Earnings Per Share |
The components of basic and diluted earnings
per share were as follows:
| |
|
For the three months ended March 31, 2020 |
|
|
For the nine months ended March 31, 2020 |
|
| |
|
Net Income |
|
|
Shares |
|
|
Per Share |
|
|
Net Loss |
|
|
Shares |
|
|
Per Share |
|
| Basic income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) available to common shareholders |
|
$ |
1,000,807 |
|
|
|
11,753,063 |
|
|
$ |
0.09 |
|
|
$ |
(241,165 |
) |
|
|
11,713,827 |
|
|
$ |
(0.02 |
) |
| Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Share grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted income (loss) per share |
|
$ |
1,000,807 |
|
|
|
11,753,063 |
|
|
$ |
0.09 |
|
|
$ |
(241,165 |
) |
|
|
11,713,827 |
|
|
$ |
(0.02 |
) |
| |
|
For the three months ended March 31, 2019 |
|
|
For the nine months ended March 31, 2019 |
|
| |
|
Net Income |
|
|
Shares |
|
|
Per Share |
|
|
Net Income |
|
|
Shares |
|
|
Per Share |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic income per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income available to common shareholders |
|
$ |
1,267,560 |
|
|
|
11,656,098 |
|
|
$ |
0.11 |
|
|
$ |
5,085,778 |
|
|
|
11,580,066 |
|
|
$ |
0.44 |
|
| Effect of dilutive securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options |
|
|
- |
|
|
|
4,948 |
|
|
|
- |
|
|
|
- |
|
|
|
5,686 |
|
|
|
- |
|
| Share grants |
|
|
- |
|
|
|
30,296 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted income per share |
|
$ |
1,267,560 |
|
|
|
11,691,342 |
|
|
$ |
0.11 |
|
|
$ |
5,085,778 |
|
|
|
11,585,752 |
|
|
$ |
0.44 |
|
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following potential dilutive shares were
excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive.
| |
|
For the Three Months |
|
|
For the Nine Months |
|
| |
|
Ended March 31, |
|
|
Ended March 31, |
|
| |
|
2020 |
|
|
2019 |
|
|
2020 |
|
|
2019 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Share Grants |
|
|
101,790 |
|
|
|
- |
|
|
|
101,790 |
|
|
|
- |
|
| |
|
|
101,790 |
|
|
|
- |
|
|
|
101,790 |
|
|
|
- |
|
|